Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guangyao Kong

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Journal of Cancer Research and Clinical Oncology|June 28, 2022
Novel insights into roles of N6-methyladenosine reader YTHDF2 in cancer progressionRui Liu, Yachun Jia, Guangyao Kong, et al.
Journal of Leukocyte Biology|February 23, 2023
RNA splicing factors in normal hematopoiesis and hematologic malignancies: novel therapeutic targets and strategiesZhenzhen Li, Zhongzheng He, Jihan Wang, et al.
Oncology Letters|July 16, 2021
Association between cellular immune response and spleen weight in mice with hepatocellular carcinomaWei Jiang, Yu Li, Shuqun Zhang, et al.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology|September 24, 2020
[Expression and significance of myeloid-derived suppressor cells-associated chemokine MIP-1γ and its receptor CCR1 in the spleen of hepatoma H22-bearing mice]Baohua Li, Haiyan Chen, Mengjiao Shi, et al.
Global Medical Genetics|December 4, 2023
Spleen-Derived CCL9 Recruits MDSC to Facilitate Tumor Growth in Orthotopic Hepatoma MiceBaohua Li, Wenjuan Li, Yingxue Liang, et al.
Plos One|May 17, 2011
Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture modelGuangyao Kong, Junping Zhang, Shuai Zhang, et al.
Plos One|February 10, 2012
MicroRNA-520b inhibits growth of hepatoma cells by targeting MEKK2 and cyclin D1Weiying Zhang, Guangyao Kong, Junping Zhang, et al.
Journal of Hepatology|January 27, 2019
Spleen in hepatocellular carcinoma: More complexity and importance than we knewWei Wei, Liang Li, Guangyao Kong, et al.
Small Gtpases|July 25, 2016
The mystery of oncogenic KRAS: Lessons from studying its wild-type counter partYuan-I Chang, Alisa Damnernsawad, Guangyao Kong, et al.
Blood|November 1, 2018
Unique dependence on Sos1 in <i>Kras</i> <sup></sup> -induced leukemogenesisXiaona You, Guangyao Kong, Erik A Ranheim, et al.
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Journal of Cancer Research and Clinical Oncology|June 28, 2022
Novel insights into roles of N6-methyladenosine reader YTHDF2 in cancer progressionRui Liu, Yachun Jia, Guangyao Kong, et al.
Journal of Leukocyte Biology|February 23, 2023
RNA splicing factors in normal hematopoiesis and hematologic malignancies: novel therapeutic targets and strategiesZhenzhen Li, Zhongzheng He, Jihan Wang, et al.
Oncology Letters|July 16, 2021
Association between cellular immune response and spleen weight in mice with hepatocellular carcinomaWei Jiang, Yu Li, Shuqun Zhang, et al.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology|September 24, 2020
[Expression and significance of myeloid-derived suppressor cells-associated chemokine MIP-1γ and its receptor CCR1 in the spleen of hepatoma H22-bearing mice]Baohua Li, Haiyan Chen, Mengjiao Shi, et al.
Global Medical Genetics|December 4, 2023
Spleen-Derived CCL9 Recruits MDSC to Facilitate Tumor Growth in Orthotopic Hepatoma MiceBaohua Li, Wenjuan Li, Yingxue Liang, et al.
Plos One|May 17, 2011
Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture modelGuangyao Kong, Junping Zhang, Shuai Zhang, et al.
Plos One|February 10, 2012
MicroRNA-520b inhibits growth of hepatoma cells by targeting MEKK2 and cyclin D1Weiying Zhang, Guangyao Kong, Junping Zhang, et al.
Journal of Hepatology|January 27, 2019
Spleen in hepatocellular carcinoma: More complexity and importance than we knewWei Wei, Liang Li, Guangyao Kong, et al.
Small Gtpases|July 25, 2016
The mystery of oncogenic KRAS: Lessons from studying its wild-type counter partYuan-I Chang, Alisa Damnernsawad, Guangyao Kong, et al.
Blood|November 1, 2018
Unique dependence on Sos1 in <i>Kras</i> <sup></sup> -induced leukemogenesisXiaona You, Guangyao Kong, Erik A Ranheim, et al.
Pageof 8